Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia

• DOI: 10.1182/blood.v99.11.4216
• Publication Date: 2002-10-01T21:48:18Z
• Authors: Martin Yuille; Alison Condie; Chantelle Hudson; Zsofia Kote-Jarai; Elaine Stone; Rosalind Eeles; Estella Matutes; Daniel Catovsky; Richard Houlston
• Keywords: Male; Polymorphism, Genetic; Genotype; enzymology; Polymorphism,Genetic; Middle Aged; Leukemia, Lymphocytic, Chronic, B-Cell; 3. Good health; Isoenzymes; 03 medical and health sciences; 0302 clinical medicine; Gene Frequency; Glutathione S-Transferase pi; Humans; Family; genetics; Female; Leukemia,Lymphocytic,Chronic,B-Cell; Glutathione Transferase

Interindividual differences in susceptibility to hematologic malignancies may be mediated in part through polymorphic variability in the bioactivation and detoxification of carcinogens. The glutathione S–transferases (GSTs) have been implicated as susceptibility genes in this context for a number of cancers. The aim of this study was to examine whether polymorphic variation in GSTs confers susceptibility to chronic lymphocytic leukemia (CLL). GSTM1, GSTT1, andGSTP1 genotypes were determined in 138 patients and 280 healthy individuals. The frequency of both GSTM1 andGSTT1 null genotypes and the GSTP1-Ile allele was higher in cases than in controls. There was evidence of a trend in increasing risk with the number of putative “high-risk” alleles of the GST family carried (P = .04). The risk of CLL associated with possession of all 3 “high-risk” genotypes was increased 2.8-fold (OR = 2.8, 95% confidence interval: 1.1-6.9). Our findings suggest that heritable GST status may influence the risk of developing CLL.